What we're reading, August 19, 2016: CMS is investigating if patients are being steered away from Medicaid and Medicare to private plans; Medicare Part D paid 17% more for drugs in 2014 than in 2013; and 5 things to know about HIPAA today.
CMS is investigating whether providers are steering patients into Affordable Care Act plans instead of Medicare or Medicaid. CMS is concerned that providers or their organizations are paying insurance premiums for patients who quality for Medicare and Medicaid because the provider receive better reimbursements from insurance companies than from the federal health programs, reported The Wall Street Journal. UnitedHealth Group has already sued a kidney-care chain for such alleged actions.
CMS paid 17% more for drugs in 2014 compared with 2013. According to Healthcare Finance, Lantus Solostar and Lantus, both insulin products, had the highest increases year over year, but hepatitis C drug Sovaldi still had the highest total drug costs at $3.1 billion. Under the Medicare Part D program, the government spent $121 billion in 2014. By comparison, while the cost to CMS increased more than 17%, the total cost of claims only increased 3.3%.
This year the Health Insurance Portability and Accountability Act, or HIPAA, turns 20 years old, and things have changed a lot since Congress passed it. With electronic medical records and genomic research, balancing privacy with third-party access to data is difficult. STAT took a look at 5 things to know about HIPAA including that your data is out there, third parties actually have better access to patients’ medical information than the patient does, and medical identity theft is rising.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More